C4 Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 10.65, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the C4 Therapeutics Inc in Jun 30 2026 quarter, has decreased to 34 days, compared to 37 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 102 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1196 to 1203.

What is Receivable Turnover Ratio?
What is C4 Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CCCC Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-38.18 %	-64.09 %	-22.6 %	-36.74 %	84.92 %
Y / Y Revenue Change	2.75 %	-15 %	112.79 %	-26.9 %	-46.17 %
Receivable Turnover Ratio (TTM)	10.65	9.97	7.52	6.07	5.8
CCCC's Total Ranking	# 1203	# 1196	# 1236	# 2999	# 2019
Accounts Receivable average collection period days	34	37	49	60	63
Seq. Receivable Change	-53.73 %	20.07 %	-63.3 %	203.15 %	-73.12 %
Seq. Revenue Change	7.95 %	-44.15 %	-1.91 %	73.76 %	-10.71 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 14
Healthcare Sector	# 103
Overall Market	# 1203

Receivable Turnover Ratio Statistics
High	Average	Low
23.06	9.69	2.98
(Sep 30 2023)		(Mar 31 2024)

CCCC Company Profile • Back to CCCC Efficiency Comparisons • Compare CCCC Receivables Turnover Ratio to its Competitors

Financial Statements
C4 Therapeutics Inc 's Accounts Receivable	$ 1 Millions	Visit CCCC's Balance sheet
C4 Therapeutics Inc 's Sales TTM	$ 35 Millions	Visit CCCC's Income Statement
Sources of CCCC's Revenues		Visit CCCC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CCCC's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CCCC's Growth Rates	CCCC's Roa	CCCC's Inventory Turnover Ratio	CCCC's Dividend Comparisons
CCCC's Profitability Ratios	CCCC's Roi	CCCC's Asset Turnover Ratio	CCCC's Dividend Growth
CCCC's Valuation Ratios	CCCC's Roe	CCCC's Financial Strength Ratios	CCCC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Airsculpt Technologies Inc	64.88	$ 150.724 Millions	$ 2.323 Millions
Arrowhead Pharmaceuticals Inc	60.05	$ 669.495 Millions	$ 11.149 Millions
Fortrea Holdings Inc	56.65	$ 2,676.500 Millions	$ 47.250 Millions
Humacyte Inc	52.69	$ 30.074 Millions	$ 0.571 Millions
Brookdale Senior Living Inc	47.66	$ 3,050.697 Millions	$ 64.009 Millions
National Vision Holdings Inc	44.61	$ 2,033.426 Millions	$ 45.586 Millions
Meiragtx Holdings Plc	40.72	$ 397.501 Millions	$ 9.762 Millions
Nature s Sunshine Products inc	39.24	$ 491.790 Millions	$ 12.532 Millions
Bioadaptives Inc	35.76	$ 0.026 Millions	$ 0.001 Millions
Lifevantage Corp	35.05	$ 180.947 Millions	$ 5.162 Millions
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Mangoceuticals Inc	31.43	$ 0.315 Millions	$ 0.010 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Jaguar Health Inc	30.23	$ 27.815 Millions	$ 0.920 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Metagenomi Therapeutics Inc	25.05	$ 13.561 Millions	$ 0.541 Millions
Sonida Senior Living Inc	22.59	$ 525.973 Millions	$ 23.283 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Ginkgo Bioworks Holdings Inc	20.32	$ 111.863 Millions	$ 5.506 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Lipocine Inc	18.36	$ 1.569 Millions	$ 0.085 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Vireo Growth Inc.	16.69	$ 511.706 Millions	$ 30.659 Millions
Neuraxis Inc	15.53	$ 5.316 Millions	$ 0.342 Millions
Agenus Inc	15.44	$ 132.693 Millions	$ 8.595 Millions
Longeveron Inc	15.03	$ 1.187 Millions	$ 0.079 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions

Date modified: 2026-09-04T10:07:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.